{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:15:48Z","timestamp":1782962148506,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ningxia Medical University Institutional Scientific Research Fund","award":["XZ2024033"],"award-info":[{"award-number":["XZ2024033"]}]},{"name":"Ningxia Medical University Institutional Scientific Research Fund","award":["XZ2024033"],"award-info":[{"award-number":["XZ2024033"]}]},{"name":"Ningxia Medical University Institutional Scientific Research Fund","award":["XZ2024033"],"award-info":[{"award-number":["XZ2024033"]}]},{"name":"Ningxia Medical University Institutional Scientific Research Fund","award":["XZ2024033"],"award-info":[{"award-number":["XZ2024033"]}]},{"name":"Ningxia Medical University Institutional Scientific Research Fund","award":["XZ2024033"],"award-info":[{"award-number":["XZ2024033"]}]},{"name":"Ningxia Medical University Institutional Scientific Research Fund","award":["XZ2024033"],"award-info":[{"award-number":["XZ2024033"]}]},{"name":"Ningxia Medical University Institutional Scientific Research Fund","award":["XZ2024033"],"award-info":[{"award-number":["XZ2024033"]}]},{"name":"Ningxia Medical University Institutional Scientific Research Fund","award":["XZ2024033"],"award-info":[{"award-number":["XZ2024033"]}]},{"name":"Ningxia Medical University Institutional Scientific Research Fund","award":["XZ2024033"],"award-info":[{"award-number":["XZ2024033"]}]},{"name":"the Ningxia Gut Homeostasis and Chronic Disease Prevention and Treatment Scientific and Technological Innovation Team, China","award":["2022BSB03112"],"award-info":[{"award-number":["2022BSB03112"]}]},{"name":"the Ningxia Gut Homeostasis and Chronic Disease Prevention and Treatment Scientific and Technological Innovation Team, China","award":["2022BSB03112"],"award-info":[{"award-number":["2022BSB03112"]}]},{"name":"the Ningxia Gut Homeostasis and Chronic Disease Prevention and Treatment Scientific and Technological Innovation Team, China","award":["2022BSB03112"],"award-info":[{"award-number":["2022BSB03112"]}]},{"name":"the Ningxia Gut Homeostasis and Chronic Disease Prevention and Treatment Scientific and Technological Innovation Team, China","award":["2022BSB03112"],"award-info":[{"award-number":["2022BSB03112"]}]},{"name":"the Ningxia Gut Homeostasis and Chronic Disease Prevention and Treatment Scientific and Technological Innovation Team, China","award":["2022BSB03112"],"award-info":[{"award-number":["2022BSB03112"]}]},{"name":"the Ningxia Gut Homeostasis and Chronic Disease Prevention and Treatment Scientific and Technological Innovation Team, China","award":["2022BSB03112"],"award-info":[{"award-number":["2022BSB03112"]}]},{"name":"the Ningxia Gut Homeostasis and Chronic Disease Prevention and Treatment Scientific and Technological Innovation Team, China","award":["2022BSB03112"],"award-info":[{"award-number":["2022BSB03112"]}]},{"name":"the Ningxia Gut Homeostasis and Chronic Disease Prevention and Treatment Scientific and Technological Innovation Team, China","award":["2022BSB03112"],"award-info":[{"award-number":["2022BSB03112"]}]},{"name":"the Ningxia Gut Homeostasis and Chronic Disease Prevention and Treatment Scientific and Technological Innovation Team, China","award":["2022BSB03112"],"award-info":[{"award-number":["2022BSB03112"]}]},{"name":"Program of Ningxia Science and Technology Leading Talent, China","award":["2023GKLRLX17"],"award-info":[{"award-number":["2023GKLRLX17"]}]},{"name":"Program of Ningxia Science and Technology Leading Talent, China","award":["2023GKLRLX17"],"award-info":[{"award-number":["2023GKLRLX17"]}]},{"name":"Program of Ningxia Science and Technology Leading Talent, China","award":["2023GKLRLX17"],"award-info":[{"award-number":["2023GKLRLX17"]}]},{"name":"Program of Ningxia Science and Technology Leading Talent, China","award":["2023GKLRLX17"],"award-info":[{"award-number":["2023GKLRLX17"]}]},{"name":"Program of Ningxia Science and Technology Leading Talent, China","award":["2023GKLRLX17"],"award-info":[{"award-number":["2023GKLRLX17"]}]},{"name":"Program of Ningxia Science and Technology Leading Talent, China","award":["2023GKLRLX17"],"award-info":[{"award-number":["2023GKLRLX17"]}]},{"name":"Program of Ningxia Science and Technology Leading Talent, China","award":["2023GKLRLX17"],"award-info":[{"award-number":["2023GKLRLX17"]}]},{"name":"Program of Ningxia Science and Technology Leading Talent, China","award":["2023GKLRLX17"],"award-info":[{"award-number":["2023GKLRLX17"]}]},{"name":"Program of Ningxia Science and Technology Leading Talent, China","award":["2023GKLRLX17"],"award-info":[{"award-number":["2023GKLRLX17"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04096-3","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T11:35:27Z","timestamp":1751888127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Intestinal microbiota in adults with cholangiocarcinoma identifies the dysregulated Blautia species and bile acid metabolic pathways"],"prefix":"10.1186","volume":"25","author":[{"given":"Tianyu","family":"De","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xusheng","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"issue":"1","key":"4096_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE, Teh BT, Wongkham S. Gores GJ: cholangiocarcinoma. Nat Reviews Disease Primers. 2021;7(1):65.","journal-title":"Nat Reviews Disease Primers"},{"issue":"9","key":"4096_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","volume":"8","author":"B Blechacz","year":"2011","unstructured":"Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Reviews Gastroenterol Hepatol. 2011;8(9):512\u201322.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"9","key":"4096_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Reviews Gastroenterol Hepatol. 2020;17(9):557\u201388.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"4","key":"4096_CR4","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41591-022-01779-2","volume":"28","author":"EM Park","year":"2022","unstructured":"Park EM, Chelvanambi M, Bhutiani N, Kroemer G, Zitvogel L, Wargo JA. Targeting the gut and tumor microbiota in cancer. Nat Med. 2022;28(4):690\u2013703.","journal-title":"Nat Med"},{"issue":"7","key":"4096_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41575-023-00771-6","volume":"20","author":"O Pabst","year":"2023","unstructured":"Pabst O, Hornef MW, Schaap FG, Cerovic V, Clavel T, Bruns T. Gut-liver axis: barriers and functional circuits. Nat Reviews Gastroenterol Hepatol. 2023;20(7):447\u201361.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"3","key":"4096_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41575-022-00690-y","volume":"20","author":"JR Hov","year":"2023","unstructured":"Hov JR, Karlsen TH. The microbiota and the gut-liver axis in primary sclerosing cholangitis. Nat Reviews Gastroenterol Hepatol. 2023;20(3):135\u201354.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"9","key":"4096_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/microorganisms11092363","volume":"11","author":"AK Lederer","year":"2023","unstructured":"Lederer AK, Rasel H, Kohnert E, Kreutz C, Huber R, Badr MT, Dellweg PKE, Bartsch F, Lang H. Gut microbiota in diagnosis, therapy and prognosis of cholangiocarcinoma and gallbladder Carcinoma-A scoping review. Microorganisms. 2023;11(9):1\u201320.","journal-title":"Microorganisms"},{"issue":"5","key":"4096_CR8","first-page":"493","volume":"29","author":"H Sang","year":"2021","unstructured":"Sang H, Li WJ, Zhou Y, Zhu H. [Advances in research on the relationship between bile acid, gut microbiota and the occurrence and development of cholangiocarcinoma]. Zhonghua Gan Zang Bing Za zhi = Zhonghua Ganzangbing Zazhi = Chin J Hepatol. 2021;29(5):493\u20136.","journal-title":"Zhonghua Gan Zang Bing Za zhi = Zhonghua Ganzangbing Zazhi = Chin J Hepatol"},{"issue":"5","key":"4096_CR9","first-page":"2962","volume":"14","author":"Z Li","year":"2022","unstructured":"Li Z, Chu J, Su F, Ding X, Zhang Y, Dou L, Liu Y, Ke Y, Liu X, Liu Y, et al. Characteristics of bile microbiota in cholelithiasis, Perihilar cholangiocarcinoma, distal cholangiocarcinoma, and pancreatic cancer. Am J Translational Res. 2022;14(5):2962\u201371.","journal-title":"Am J Translational Res"},{"issue":"1","key":"4096_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12957-020-1793-3","volume":"18","author":"H Lee","year":"2020","unstructured":"Lee H, Lee HK, Min SK, Lee WH. 16S rDNA Microbiome composition pattern analysis as a diagnostic biomarker for biliary tract cancer. World J Surg Oncol. 2020;18(1):19.","journal-title":"World J Surg Oncol"},{"issue":"5","key":"4096_CR11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41416-021-01583-8","volume":"126","author":"RC Wheatley","year":"2022","unstructured":"Wheatley RC, Kilgour E, Jacobs T, Lamarca A, Hubner RA, Valle JW, McNamara MG. Potential influence of the Microbiome environment in patients with biliary tract cancer and implications for therapy. Br J Cancer. 2022;126(5):693\u2013705.","journal-title":"Br J Cancer"},{"issue":"1","key":"4096_CR12","doi-asserted-by":"publisher","first-page":"e00292","DOI":"10.14309\/ctg.0000000000000292","volume":"12","author":"T Ketpueak","year":"2020","unstructured":"Ketpueak T, Thiennimitr P, Apaijai N, Chattipakorn SC, Chattipakorn N. Association of chronic Opisthorchis infestation and microbiota alteration on tumorigenesis in cholangiocarcinoma. Clin Translational Gastroenterol. 2020;12(1):e00292.","journal-title":"Clin Translational Gastroenterol"},{"key":"4096_CR13","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3389\/fmicb.2015.00771","volume":"6","author":"J Tremblay","year":"2015","unstructured":"Tremblay J, Singh K, Fern A, Kirton ES, He S, Woyke T, Lee J, Chen F, Dangl JL, Tringe SG. Primer and platform effects on 16S rRNA Tag sequencing. Front Microbiol. 2015;6:771.","journal-title":"Front Microbiol"},{"key":"4096_CR14","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/1471-2180-13-208","volume":"13","author":"Y He","year":"2013","unstructured":"He Y, Zhou BJ, Deng GH, Jiang XT, Zhang H, Zhou HW. Comparison of microbial diversity determined with the same variable Tag sequence extracted from two different PCR amplicons. BMC Microbiol. 2013;13:208.","journal-title":"BMC Microbiol"},{"issue":"17","key":"4096_CR15","first-page":"i884","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinf (Oxford England). 2018;34(17):i884\u201390.","journal-title":"Bioinf (Oxford England)"},{"issue":"5","key":"4096_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26(5):589\u201395.","journal-title":"Bioinformatics"},{"issue":"10","key":"4096_CR17","first-page":"1674","volume":"31","author":"D Li","year":"2015","unstructured":"Li D, Liu CM, Luo R, Sadakane K, Lam TW. MEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph. Bioinf (Oxford England). 2015;31(10):1674\u20136.","journal-title":"Bioinf (Oxford England)"},{"key":"4096_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1471-2105-11-119","volume":"11","author":"D Hyatt","year":"2010","unstructured":"Hyatt D, Chen GL, Locascio PF, Land ML, Larimer FW, Hauser LJ. Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinformatics. 2010;11:119.","journal-title":"BMC Bioinformatics"},{"issue":"23","key":"4096_CR19","first-page":"3150","volume":"28","author":"L Fu","year":"2012","unstructured":"Fu L, Niu B, Zhu Z, Wu S, Li W. CD-HIT: accelerated for clustering the next-generation sequencing data. Bioinf (Oxford England). 2012;28(23):3150\u20132.","journal-title":"Bioinf (Oxford England)"},{"issue":"5","key":"4096_CR20","first-page":"713","volume":"24","author":"R Li","year":"2008","unstructured":"Li R, Li Y, Kristiansen K, Wang J. SOAP: short oligonucleotide alignment program. Bioinf (Oxford England). 2008;24(5):713\u20134.","journal-title":"Bioinf (Oxford England)"},{"issue":"1","key":"4096_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nmeth.3176","volume":"12","author":"B Buchfink","year":"2015","unstructured":"Buchfink B, Xie C, Huson DH. Fast and sensitive protein alignment using DIAMOND. Nat Methods. 2015;12(1):59\u201360.","journal-title":"Nat Methods"},{"issue":"10272","key":"4096_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","volume":"397","author":"JW Valle","year":"2021","unstructured":"Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Biliary tract cancer. Lancet (London England). 2021;397(10272):428\u201344.","journal-title":"Lancet (London England)"},{"issue":"12","key":"4096_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells12121576","volume":"12","author":"V Cossiga","year":"2023","unstructured":"Cossiga V, Guarino M, Capasso M, Morisco F. Relevance of bile acids in cholangiocarcinoma pathogenesis: critical revision and future directions. Cells. 2023;12(12):1\u201313.","journal-title":"Cells"},{"issue":"7","key":"4096_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI154944","volume":"132","author":"CR Wensel","year":"2022","unstructured":"Wensel CR, Pluznick JL, Salzberg SL, Sears CL. Next-generation sequencing: insights to advance clinical investigations of the Microbiome. J Clin Invest. 2022;132(7):1\u201312.","journal-title":"J Clin Invest"},{"key":"4096_CR25","doi-asserted-by":"crossref","unstructured":"Elvevi A, Laffusa A, Gallo C, Invernizzi P, Massironi S. Any role for microbiota in cholangiocarcinoma?? A comprehensive review. Cells. 2023;12(3):1\u201314.","DOI":"10.3390\/cells12030370"},{"issue":"7813","key":"4096_CR26","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","volume":"582","author":"M Funabashi","year":"2020","unstructured":"Funabashi M, Grove TL, Wang M, Varma Y, McFadden ME, Brown LC, Guo C, Higginbottom S, Almo SC, Fischbach MA. A metabolic pathway for bile acid dehydroxylation by the gut Microbiome. Nature. 2020;582(7813):566\u201370.","journal-title":"Nature"},{"issue":"3","key":"4096_CR27","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/hep.30852","volume":"71","author":"X Jia","year":"2020","unstructured":"Jia X, Lu S, Zeng Z, Liu Q, Dong Z, Chen Y, Zhu Z, Hong Z, Zhang T, Du G, et al. Characterization of gut microbiota, bile acid metabolism, and cytokines in intrahepatic cholangiocarcinoma. Hepatology (Baltimore MD). 2020;71(3):893\u2013906.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"21","key":"4096_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers14215379","volume":"14","author":"Z Ito","year":"2022","unstructured":"Ito Z, Koido S, Kato K, Odamaki T, Horiuchi S, Akasu T, Saruta M, Hata T, Kumagai Y, Fujioka S, et al. Dysbiosis of the Fecal and Biliary Microbiota in Biliary Tract Cancer. Cancers. 2022;14(21):1\u201312.","journal-title":"Cancers"},{"issue":"3","key":"4096_CR29","doi-asserted-by":"publisher","first-page":"e0247798","DOI":"10.1371\/journal.pone.0247798","volume":"16","author":"M Saab","year":"2021","unstructured":"Saab M, Mestivier D, Sohrabi M, Rodriguez C, Khonsari MR, Faraji A, Sobhani I. Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma. PLoS ONE. 2021;16(3):e0247798.","journal-title":"PLoS ONE"},{"issue":"5","key":"4096_CR30","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/gutjnl-2020-323565","volume":"71","author":"Q Liu","year":"2022","unstructured":"Liu Q, Li B, Li Y, Wei Y, Huang B, Liang J, You Z, Li Y, Qian Q, Wang R, et al. Altered faecal Microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis. Gut. 2022;71(5):899\u2013909.","journal-title":"Gut"},{"issue":"12","key":"4096_CR31","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1093\/ecco-jcc\/jjae096","volume":"18","author":"H Leibovitzh","year":"2024","unstructured":"Leibovitzh H, Nayeri S, Borowski K, Hernandez-Rocha C, Lee SH, Turpin W, Stempak JM, Sandhu I, Milgrom R, Smith MI, et al. Inflammatory bowel disease associated with primary sclerosing cholangitis is associated with an altered gut Microbiome and bile acid profile. J Crohn\u2019s Colitis. 2024;18(12):1957\u201366.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"1","key":"4096_CR32","doi-asserted-by":"publisher","first-page":"8233","DOI":"10.1080\/21655979.2021.1982273","volume":"12","author":"T Chen","year":"2021","unstructured":"Chen T, Ding R, Chen X, Lu Y, Shi J, L\u00fc Y, Tang B, Zhang W, Ye C, Yuan M, et al. Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study. Bioengineered. 2021;12(1):8233\u201346.","journal-title":"Bioengineered"},{"issue":"1","key":"4096_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41522-023-00398-0","volume":"9","author":"H Leung","year":"2023","unstructured":"Leung H, Xiong L, Ni Y, Busch A, Bauer M, Press AT, Panagiotou G. Impaired flux of bile acids from the liver to the gut reveals microbiome-immune interactions associated with liver damage. NPJ Biofilms Microbiomes. 2023;9(1):35.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"1","key":"4096_CR34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/2050640617708953","volume":"6","author":"J Torres","year":"2018","unstructured":"Torres J, Palmela C, Brito H, Bao X, Ruiqi H, Moura-Santos P, Pereira da Silva J, Oliveira A, Vieira C, Perez K. The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease. United Eur Gastroenterol J. 2018;6(1):112\u201322.","journal-title":"United Eur Gastroenterol J"},{"issue":"1","key":"4096_CR35","doi-asserted-by":"publisher","first-page":"11406","DOI":"10.1038\/s41598-023-38307-2","volume":"13","author":"Y Pomyen","year":"2023","unstructured":"Pomyen Y, Chaisaingmongkol J, Rabibhadana S, Pupacdi B, Sripan D, Chornkrathok C, Budhu A, Budhisawasdi V, Lertprasertsuke N, Chotirosniramit A, et al. Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Sci Rep. 2023;13(1):11406.","journal-title":"Sci Rep"},{"issue":"3","key":"4096_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","volume":"30","author":"J Cai","year":"2022","unstructured":"Cai J, Sun L, Gonzalez FJ. Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis. Cell Host Microbe. 2022;30(3):289\u2013300.","journal-title":"Cell Host Microbe"},{"issue":"7","key":"4096_CR37","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1053\/j.gastro.2023.02.022","volume":"164","author":"KA Fogelson","year":"2023","unstructured":"Fogelson KA, Dorrestein PC, Zarrinpar A, Knight R. The gut microbial bile acid modulation and its relevance to digestive health and diseases. Gastroenterology. 2023;164(7):1069\u201385.","journal-title":"Gastroenterology"},{"issue":"5","key":"4096_CR38","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","volume":"71","author":"WM de Vos","year":"2022","unstructured":"de Vos WM, Tilg H, Van Hul M, Cani PD. Gut Microbiome and health: mechanistic insights. Gut. 2022;71(5):1020\u201332.","journal-title":"Gut"},{"key":"4096_CR39","doi-asserted-by":"publisher","first-page":"1127743","DOI":"10.3389\/fimmu.2023.1127743","volume":"14","author":"X Su","year":"2023","unstructured":"Su X, Gao Y, Yang R. Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity. Front Immunol. 2023;14:1127743.","journal-title":"Front Immunol"},{"key":"4096_CR40","doi-asserted-by":"publisher","first-page":"1288525","DOI":"10.3389\/fmicb.2023.1288525","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen Z, Shi W, Chen K, Lu C, Li X, Li Q. Elucidating the causal association between gut microbiota and intrahepatic cholangiocarcinoma through Mendelian randomization analysis. Front Microbiol. 2023;14:1288525.","journal-title":"Front Microbiol"},{"key":"4096_CR41","doi-asserted-by":"publisher","first-page":"108238","DOI":"10.1016\/j.pharmthera.2022.108238","volume":"237","author":"J Cai","year":"2022","unstructured":"Cai J, Rimal B, Jiang C, Chiang JYL, Patterson AD. Bile acid metabolism and signaling, the microbiota, and metabolic disease. Pharmacol Ther. 2022;237:108238.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"4096_CR42","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","volume":"21","author":"SL Collins","year":"2023","unstructured":"Collins SL, Stine JG, Bisanz JE, Okafor CD, Patterson AD. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat Rev Microbiol. 2023;21(4):236\u201347.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"4096_CR43","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s11427-023-2353-0","volume":"67","author":"W Jia","year":"2024","unstructured":"Jia W, Li Y, Cheung KCP, Zheng X. Bile acid signaling in the regulation of whole body metabolic and immunological homeostasis. Sci China Life Sci. 2024;67(5):865\u201378.","journal-title":"Sci China Life Sci"},{"key":"4096_CR44","doi-asserted-by":"publisher","first-page":"6069403","DOI":"10.1155\/2022\/6069403","volume":"2022","author":"Z Han","year":"2022","unstructured":"Han Z, Zhang H, Lu L, Li X, Zhang C, Zhu J, Li C, Wang Q, Chen K. Research Progress in Intestinal Microecology in Pancreatic Cancer Diagnosis and Treatment. J Oncol. 2022;2022:6069403.","journal-title":"J Oncol."},{"issue":"7","key":"4096_CR45","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.4103\/jcrt.jcrt_1444_22","volume":"18","author":"J Wang","year":"2022","unstructured":"Wang J, Liang J, He M, Xie Q, Wu Q, Shen G, Zhu B, Yu J, Yu L, Tan X, et al. Chinese expert consensus on intestinal microecology and management of digestive tract complications related to tumor treatment (version 2022). J Cancer Res Ther. 2022;18(7):1835\u201344.","journal-title":"J Cancer Res Ther"},{"issue":"1","key":"4096_CR46","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1038\/s41467-023-37590-x","volume":"14","author":"C Xu","year":"2023","unstructured":"Xu C, Gu L, Hu L, Jiang C, Li Q, Sun L, Zhou H, Liu Y, Xue H, Li J, et al. FADS1-arachidonic acid axis enhances arachidonic acid metabolism by altering intestinal microecology in colorectal cancer. Nat Commun. 2023;14(1):2042.","journal-title":"Nat Commun"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04096-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04096-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04096-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T13:02:21Z","timestamp":1751893341000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04096-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4096"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04096-3","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Research Ethics Review Committee of Ningxia Medical University General Hospital (KYLL-2024-1316). All procedures of this study were performed following the principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"506"}}